Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 4 von 835
Oncotarget, 2015-07, Vol.6 (21), p.18250-18264
2015
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder
Ist Teil von
  • Oncotarget, 2015-07, Vol.6 (21), p.18250-18264
Ort / Verlag
United States: Impact Journals LLC
Erscheinungsjahr
2015
Quelle
Free E-Journal (出版社公開部分のみ)
Beschreibungen/Notizen
  • Although more than 90% systemic mastocytosis (SM) patients express gain of function mutations in the KIT receptor, recent next generation sequencing has revealed the presence of several additional genetic and epigenetic mutations in a subset of these patients, which confer poor prognosis and inferior overall survival. A clear understanding of how genetic and epigenetic mutations cooperate in regulating the tremendous heterogeneity observed in these patients will be essential for designing effective treatment strategies for this complex disease. In this review, we describe the clinical heterogeneity observed in patients with mastocytosis, the nature of relatively novel mutations identified in these patients, therapeutic strategies to target molecules downstream from activating KIT receptor and finally we speculate on potential novel strategies to interfere with the function of not only the oncogenic KIT receptor but also epigenetic mutations seen in these patients.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX